Pancreatic Cancer Research

ResearcherNankai UniversityNo recent work listed

Dengwen Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4573-7191; OpenAlex author ID A5058127847. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 6

  1. CYLD deficiency promotes pancreatic cancer development by causing mitotic defects. Co-author DOI 10.1002/jcp.27658↗
  2. EB1 phosphorylation mediates the functions of ASK1 in pancreatic cancer development. Co-author DOI 10.18632/oncotarget.21004↗
  3. Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization. Co-author DOI 10.1038/srep21263↗
  4. Apoptosis signal-regulating kinase 1 exhibits oncogenic activity in pancreatic cancer. Co-author DOI 10.18632/oncotarget.12090↗
  5. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells. Co-author DOI 10.1007/s13238-013-0010-3↗
  6. Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. Last author DOI 10.4161/cbt.21412↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Zhou · 6 shared papers, 2012–2019 · strength 0.36
  2. Min Liu · 6 shared papers, 2012–2019 · strength 0.36
  3. Songbo Xie · 4 shared papers, 2013–2019 · strength 0.25
  4. Youguang Luo · 2 shared papers, 2016–2017 · strength 0.13
  5. Siqi Gao · 2 shared papers, 2016–2017 · strength 0.13
  6. Xiaodong Sun · 2 shared papers, 2012–2013 · strength 0.07
  7. Shiyu Liu · 1 shared paper, 2016 · strength 0.06
  8. Chao Zhang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.